Ledercort Rx (Mometasone Furoate Ph. Eur.)

Mometasone furoate binds to glucocorticoid receptors inside nasal mucosal cells. This binding changes gene expression, lowering the production of inflammatory cytokines and chemokines. The result is reduced swelling, mucus production and immune cell infiltration, leading to symptom relief.

The exact dose of Ledercort Rx is determined by the prescribing clinician based on the patient’s age, severity of symptoms and treatment response. The prescriber will provide specific instructions on the number of sprays per nostril and frequency of use.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare professional before starting treatment.

To request Ledercort Rx, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ledercort Rx contains mometasone furoate, a high‑potency glucocorticoid with minimal systemic absorption when used as directed. Compared with lower‑potency agents such as fluticasone, mometasone often provides effective symptom control at similar or lower dosing frequencies, but choice depends on individual response and physician preference.

Store Ledercort Rx at room temperature, below 25 °C (77 °F). Keep the bottle in its original packaging, protect it from moisture, direct sunlight and extreme heat to maintain product stability.

Ledercort Rx is a metered‑dose nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, close the opposite nostril, and press the actuator while breathing in gently through the nose. The same procedure is repeated for the other side as prescribed.

Serious risks, though rare, include adrenal suppression with prolonged high‑dose use, cataracts or glaucoma, severe allergic reactions (anaphylaxis), and opportunistic fungal infections of the nasal mucosa. Any signs of these conditions should prompt immediate medical evaluation.

Ledercort Rx should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients who have active, untreated nasal infections or recent nasal surgery unless directed by a physician.